|
|
dna recombination
|
GO:0006310 |
92 |
1.000
|
|
|
|
v d j recombination
|
GO:0033151 |
14 |
0.999
|
|
|
|
telomere capping
|
GO:0016233 |
4 |
0.999
|
|
|
|
dna repair
|
GO:0006281 |
107 |
0.998
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.995
|
|
|
|
somatic cell dna recombination
|
GO:0016444 |
51 |
0.992
|
|
|
|
cellular hyperosmotic salinity response
|
GO:0071475 |
0 |
0.991
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.976
|
|
|
|
somatic recombination of immunoglobulin gene segments
|
GO:0016447 |
42 |
0.973
|
|
|
|
somatic diversification of immune receptors via germline recombination within a single locus
|
GO:0002562 |
51 |
0.967
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.962
|
|
|
|
double strand break repair
|
GO:0006302 |
48 |
0.958
|
|
|
|
immature b cell differentiation
|
GO:0002327 |
10 |
0.942
|
|
|
|
non recombinational repair
|
GO:0000726 |
10 |
0.939
|
|
|
|
somatic diversification of immunoglobulins involved in immune response
|
GO:0002208 |
36 |
0.937
|
|
|
|
response to x ray
|
GO:0010165 |
11 |
0.934
|
|
|
|
telomere maintenance
|
GO:0000723 |
19 |
0.931
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.931
|
|
|
|
cellular response to gamma radiation
|
GO:0071480 |
4 |
0.925
|
|
|
|
somatic diversification of immune receptors
|
GO:0002200 |
53 |
0.879
|
|
|
|
immunoglobulin production
|
GO:0002377 |
73 |
0.861
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.759
|
|
|
|
positive regulation of gene silencing by mirna
|
GO:2000637 |
1 |
0.740
|
|
|
|
response to ionizing radiation
|
GO:0010212 |
42 |
0.718
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.672
|
|
|
|
b cell activation involved in immune response
|
GO:0002312 |
50 |
0.592
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.560
|
|
|
|
reciprocal dna recombination
|
GO:0035825 |
16 |
0.554
|
|
|
|
immunoglobulin mediated immune response
|
GO:0016064 |
69 |
0.519
|
|
|
|
cellular response to radiation
|
GO:0071478 |
28 |
0.513
|
|
|
|
positive regulation of protein oligomerization
|
GO:0032461 |
4 |
0.501
|
|
|
|
somatic diversification of t cell receptor genes
|
GO:0002568 |
5 |
0.477
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.456
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.419
|
|
|
|
intra s dna damage checkpoint
|
GO:0031573 |
4 |
0.409
|
|
|
|
somatic recombination of immunoglobulin genes involved in immune response
|
GO:0002204 |
36 |
0.407
|
|
|
|
signal transduction involved in mitotic dna damage checkpoint
|
GO:1902402 |
3 |
0.400
|
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.393
|
|
|
|
spleen development
|
GO:0048536 |
39 |
0.378
|
|
|
|
histone h4 k16 acetylation
|
GO:0043984 |
3 |
0.349
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.346
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.337
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.337
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.322
|
|
|
|
chromatin silencing
|
GO:0006342 |
15 |
0.320
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.318
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.316
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.316
|
|
|
|
nucleic acid phosphodiester bond hydrolysis
|
GO:0090305 |
49 |
0.314
|
|
|
|
nucleotide excision repair
|
GO:0006289 |
13 |
0.310
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.307
|
|
|
|
t cell receptor v d j recombination
|
GO:0033153 |
5 |
0.303
|
|
|
|
double strand break repair via nonhomologous end joining
|
GO:0006303 |
10 |
0.295
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.291
|
|
|
|
lymphocyte homeostasis
|
GO:0002260 |
64 |
0.280
|
|
|
|
dna catabolic process
|
GO:0006308 |
19 |
0.267
|
|
|
|
immunoglobulin production involved in immunoglobulin mediated immune response
|
GO:0002381 |
43 |
0.263
|
|
|
|
replicative senescence
|
GO:0090399 |
2 |
0.260
|
|
|
|
t cell homeostasis
|
GO:0043029 |
35 |
0.259
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.252
|
|
|
|
response to purine containing compound
|
GO:0014074 |
28 |
0.234
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.232
|
|
|
|
signal transduction involved in dna integrity checkpoint
|
GO:0072401 |
3 |
0.232
|
|
|
|
dna damage response signal transduction resulting in transcription
|
GO:0042772 |
2 |
0.226
|
|
|
|
isotype switching
|
GO:0045190 |
36 |
0.219
|
|
|
|
t cell apoptotic process
|
GO:0070231 |
39 |
0.217
|
|
|
|
somatic recombination of t cell receptor gene segments
|
GO:0002681 |
5 |
0.217
|
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
42 |
0.213
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.204
|
|
|
|
positive regulation of histone h3 k9 methylation
|
GO:0051574 |
4 |
0.203
|
|
|
|
dendrite regeneration
|
GO:0031104 |
1 |
0.200
|
|
|
|
protection from non homologous end joining at telomere
|
GO:0031848 |
4 |
0.199
|
|
|
|
immunoglobulin v d j recombination
|
GO:0033152 |
5 |
0.195
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.192
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.189
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.181
|
|
|
|
pre b cell differentiation
|
GO:0002329 |
7 |
0.176
|
|
|
|
phosphatidylinositol biosynthetic process
|
GO:0006661 |
15 |
0.174
|
|
|
|
meiotic chromosome segregation
|
GO:0045132 |
19 |
0.172
|
|
|
|
gene silencing by mirna
|
GO:0035195 |
10 |
0.162
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.162
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.161
|
|
|
|
dna damage response signal transduction by p53 class mediator resulting in transcription of p21 class mediator
|
GO:0006978 |
2 |
0.160
|
|
|
|
dna catabolic process exonucleolytic
|
GO:0000738 |
3 |
0.159
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
57 |
0.157
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.154
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.152
|
|
|
|
phosphatidylinositol metabolic process
|
GO:0046488 |
45 |
0.147
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.145
|
|
|
|
response to uv
|
GO:0009411 |
44 |
0.142
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.142
|
|
|
|
positive regulation of neuron death
|
GO:1901216 |
28 |
0.136
|
|
|
|
regulation of b cell differentiation
|
GO:0045577 |
23 |
0.132
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.129
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.127
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.124
|
|
|
|
cellular response to ionizing radiation
|
GO:0071479 |
11 |
0.121
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.119
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.119
|
|
|
|
dna methylation
|
GO:0006306 |
43 |
0.118
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.118
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.116
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.116
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.112
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.112
|
|
|
|
positive regulation of protein homooligomerization
|
GO:0032464 |
3 |
0.110
|
|
|
|
telomere maintenance in response to dna damage
|
GO:0043247 |
4 |
0.108
|
|
|
|
phosphatidylinositol 3 phosphate biosynthetic process
|
GO:0036092 |
6 |
0.107
|
|
|
|
schwann cell proliferation
|
GO:0014010 |
2 |
0.106
|
|
|
|
leukocyte homeostasis
|
GO:0001776 |
79 |
0.104
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.104
|
|
|
|
histone mrna metabolic process
|
GO:0008334 |
3 |
0.103
|
|
|
|
reciprocal meiotic recombination
|
GO:0007131 |
16 |
0.103
|
|
|
|
response to uv b
|
GO:0010224 |
5 |
0.103
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.103
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.102
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.102
|
|
|
|
b cell homeostatic proliferation
|
GO:0002358 |
2 |
0.101
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.099
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.099
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.098
|
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
71 |
0.097
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.096
|
|
|
|
pre mirna processing
|
GO:0031054 |
3 |
0.095
|
|
|
|
meiosis i
|
GO:0007127 |
60 |
0.095
|
|
|
|
positive regulation of reactive oxygen species biosynthetic process
|
GO:1903428 |
2 |
0.095
|
|
|
|
negative regulation of dna replication
|
GO:0008156 |
4 |
0.094
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.094
|
|
|
|
thymocyte apoptotic process
|
GO:0070242 |
19 |
0.093
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.093
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.093
|
|
|
|
response to gamma radiation
|
GO:0010332 |
22 |
0.092
|
|
|
|
rna catabolic process
|
GO:0006401 |
29 |
0.090
|
|
|
|
glial cell apoptotic process
|
GO:0034349 |
3 |
0.090
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.089
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.089
|
|
|
|
positive regulation of neuron apoptotic process
|
GO:0043525 |
25 |
0.088
|
|
|
|
response to alkaloid
|
GO:0043279 |
34 |
0.087
|
|
|
|
positive regulation of chromosome organization
|
GO:2001252 |
33 |
0.086
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.083
|
|
|
|
protein autophosphorylation
|
GO:0046777 |
61 |
0.082
|
|
|
|
mitotic g1 dna damage checkpoint
|
GO:0031571 |
4 |
0.081
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.079
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.078
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.078
|
|
|
|
positive regulation of apoptotic process involved in mammary gland involution
|
GO:0060058 |
4 |
0.078
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.077
|
|
|
|
negative regulation of lymphocyte apoptotic process
|
GO:0070229 |
24 |
0.077
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.076
|
|
|
|
cd4 positive cd25 positive alpha beta regulatory t cell differentiation
|
GO:0002361 |
4 |
0.076
|
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.074
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.074
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.074
|
|
|
|
retina homeostasis
|
GO:0001895 |
23 |
0.073
|
|
|
|
signal transduction involved in mitotic cell cycle checkpoint
|
GO:0072413 |
3 |
0.073
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.073
|
|
|
|
positive regulation of histone modification
|
GO:0031058 |
28 |
0.073
|
|
|
|
regulation of histone h3 k9 methylation
|
GO:0051570 |
8 |
0.072
|
|
|
|
regulation of t cell apoptotic process
|
GO:0070232 |
28 |
0.071
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.071
|
|
|
|
negative regulation of mammary gland epithelial cell proliferation
|
GO:0033600 |
3 |
0.071
|
|
|
|
positive regulation of b cell differentiation
|
GO:0045579 |
13 |
0.070
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.069
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.068
|
|
|
|
cytoplasmic pattern recognition receptor signaling pathway in response to virus
|
GO:0039528 |
4 |
0.067
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.066
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.065
|
|
|
|
dna catabolic process endonucleolytic
|
GO:0000737 |
15 |
0.065
|
|
|
|
pro b cell differentiation
|
GO:0002328 |
10 |
0.063
|
|
|
|
cellular response to x ray
|
GO:0071481 |
2 |
0.063
|
|
|
|
positive regulation of posttranscriptional gene silencing
|
GO:0060148 |
1 |
0.063
|
|
|
|
regulation of protein homooligomerization
|
GO:0032462 |
3 |
0.062
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.062
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.061
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.061
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.061
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.061
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.061
|
|
|
|
b cell mediated immunity
|
GO:0019724 |
71 |
0.060
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.060
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.060
|
|
|
|
male meiosis i
|
GO:0007141 |
16 |
0.060
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.060
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.059
|
|
|
|
mrna 3 end processing
|
GO:0031124 |
16 |
0.059
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.058
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.057
|
|
|
|
glycerophospholipid metabolic process
|
GO:0006650 |
71 |
0.057
|
|
|
|
dna damage checkpoint
|
GO:0000077 |
26 |
0.056
|
|
|
|
schwann cell differentiation
|
GO:0014037 |
26 |
0.056
|
|
|
|
recombinational repair
|
GO:0000725 |
21 |
0.055
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.055
|
|
|
|
positive regulation of gamma delta t cell differentiation
|
GO:0045588 |
6 |
0.055
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.055
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.055
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.055
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.055
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.055
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.054
|
|
|
|
positive regulation of chromatin modification
|
GO:1903310 |
28 |
0.054
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.053
|
|
|
|
regulation of calcium ion transport into cytosol
|
GO:0010522 |
31 |
0.053
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.053
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.053
|
|
|
|
hyperosmotic salinity response
|
GO:0042538 |
1 |
0.052
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.052
|
|
|
|
cell cycle checkpoint
|
GO:0000075 |
47 |
0.051
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.051
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.050
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.050
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.049
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.049
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
45 |
0.049
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.048
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.048
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.048
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.048
|
|
|
|
regulation of protein oligomerization
|
GO:0032459 |
4 |
0.048
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.048
|
|
|
|
telomere maintenance via telomerase
|
GO:0007004 |
1 |
0.047
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
58 |
0.047
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.047
|
|
|
|
lymphocyte apoptotic process
|
GO:0070227 |
54 |
0.047
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.047
|
|
|
|
positive regulation of mitotic sister chromatid separation
|
GO:1901970 |
2 |
0.047
|
|
|
|
long term synaptic potentiation
|
GO:0060291 |
25 |
0.046
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.046
|
|
|
|
fibroblast proliferation
|
GO:0048144 |
35 |
0.046
|
|
|
|
adherens junction organization
|
GO:0034332 |
28 |
0.046
|
|
|
|
positive regulation of glial cell proliferation
|
GO:0060252 |
4 |
0.046
|
|
|
|
cellular response to water stimulus
|
GO:0071462 |
1 |
0.045
|
|
|
|
rig i signaling pathway
|
GO:0039529 |
4 |
0.045
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.045
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.045
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.045
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.045
|
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
55 |
0.045
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.044
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.044
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.044
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.044
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.043
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.043
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.043
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.043
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
57 |
0.043
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.043
|
|
|
|
t helper cell differentiation
|
GO:0042093 |
28 |
0.043
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.042
|
|
|
|
positive regulation of extrinsic apoptotic signaling pathway
|
GO:2001238 |
34 |
0.042
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.042
|
|
|
|
chromosome segregation
|
GO:0007059 |
48 |
0.042
|
|
|
|
rna phosphodiester bond hydrolysis
|
GO:0090501 |
19 |
0.042
|
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.042
|
|
|
|
cell aging
|
GO:0007569 |
35 |
0.042
|
|
|
|
regulation of response to dna damage stimulus
|
GO:2001020 |
34 |
0.041
|
|
|
|
positive regulation of release of cytochrome c from mitochondria
|
GO:0090200 |
5 |
0.041
|
|
|
|
regulation of leukocyte apoptotic process
|
GO:2000106 |
56 |
0.041
|
|
|
|
positive regulation of protein autophosphorylation
|
GO:0031954 |
4 |
0.041
|
|
|
|
regulation of alpha beta t cell differentiation
|
GO:0046637 |
35 |
0.040
|
|
|
|
mrna metabolic process
|
GO:0016071 |
84 |
0.040
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.040
|
|
|
|
negative regulation of b cell proliferation
|
GO:0030889 |
13 |
0.040
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.039
|
|
|
|
regulation of b cell proliferation
|
GO:0030888 |
39 |
0.039
|
|
|
|
signal transduction involved in mitotic dna integrity checkpoint
|
GO:1902403 |
3 |
0.039
|
|
|
|
positive regulation of regulatory t cell differentiation
|
GO:0045591 |
4 |
0.039
|
|
|
|
dna dependent dna replication
|
GO:0006261 |
24 |
0.039
|
|
|
|
regulation of androgen receptor signaling pathway
|
GO:0060765 |
3 |
0.039
|
|
|
|
regulation of mitochondrial membrane permeability
|
GO:0046902 |
17 |
0.039
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.038
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.037
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.037
|
|
|
|
positive regulation of lymphocyte apoptotic process
|
GO:0070230 |
13 |
0.036
|
|
|
|
somatic hypermutation of immunoglobulin genes
|
GO:0016446 |
7 |
0.036
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.036
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.036
|
|
|
|
negative regulation of b cell activation
|
GO:0050869 |
27 |
0.036
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.036
|
|
|
|
nuclear transcribed mrna catabolic process
|
GO:0000956 |
16 |
0.036
|
|
|
|
base excision repair
|
GO:0006284 |
9 |
0.036
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.035
|
|
|
|
response to testosterone
|
GO:0033574 |
3 |
0.035
|
|
|
|
response to starvation
|
GO:0042594 |
65 |
0.034
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.034
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.034
|
|
|
|
positive regulation of transcription by galactose
|
GO:0000411 |
1 |
0.034
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.034
|
|
|
|
negative regulation of histone methylation
|
GO:0031061 |
10 |
0.034
|
|
|
|
mitochondrial dna repair
|
GO:0043504 |
3 |
0.034
|
|
|
|
mitotic cell cycle checkpoint
|
GO:0007093 |
31 |
0.034
|
|
|
|
negative regulation of dna dependent dna replication
|
GO:2000104 |
1 |
0.034
|
|
|
|
regulation of mitosis
|
GO:0007088 |
29 |
0.034
|
|
|
|
dna damage response signal transduction by p53 class mediator resulting in cell cycle arrest
|
GO:0006977 |
3 |
0.034
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.034
|
|
|
|
regulation of muscle cell apoptotic process
|
GO:0010660 |
17 |
0.033
|
|
|
|
glycerophospholipid biosynthetic process
|
GO:0046474 |
32 |
0.032
|
|
|
|
metaphase plate congression
|
GO:0051310 |
2 |
0.032
|
|
|
|
mitochondrial outer membrane permeabilization involved in programmed cell death
|
GO:1902686 |
11 |
0.032
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.032
|
|
|
|
phospholipid biosynthetic process
|
GO:0008654 |
36 |
0.032
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.032
|
|
|
|
cellular response to steroid hormone stimulus
|
GO:0071383 |
33 |
0.032
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.031
|
|
|
|
sister chromatid cohesion
|
GO:0007062 |
12 |
0.031
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.031
|
|
|
|
regulation of lymphocyte apoptotic process
|
GO:0070228 |
41 |
0.031
|
|
|
|
apoptotic process involved in mammary gland involution
|
GO:0060057 |
4 |
0.031
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.031
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.031
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.031
|
|
|
|
nucleobase containing compound transport
|
GO:0015931 |
27 |
0.031
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.031
|
|
|
|
regulation of histone h3 k4 methylation
|
GO:0051569 |
12 |
0.031
|
|
|
|
cellularization
|
GO:0007349 |
1 |
0.031
|
|
|
|
fatty acid biosynthetic process
|
GO:0006633 |
41 |
0.031
|
|
|
|
negative regulation of histone h3 k9 methylation
|
GO:0051573 |
4 |
0.030
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.030
|
|
|
|
intracellular signal transduction involved in g1 dna damage checkpoint
|
GO:1902400 |
3 |
0.030
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.030
|
|
|
|
somatic diversification of immune receptors via somatic mutation
|
GO:0002566 |
8 |
0.030
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.030
|
|
|
|
positive regulation of mesoderm development
|
GO:2000382 |
2 |
0.030
|
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
45 |
0.029
|
|
|
|
metaphase anaphase transition of mitotic cell cycle
|
GO:0007091 |
9 |
0.029
|
|
|
|
fibroblast apoptotic process
|
GO:0044346 |
9 |
0.029
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.029
|
|
|
|
rna phosphodiester bond hydrolysis endonucleolytic
|
GO:0090502 |
10 |
0.029
|
|
|
|
positive regulation of histone h3 k4 methylation
|
GO:0051571 |
5 |
0.029
|
|
|
|
negative regulation of innate immune response
|
GO:0045824 |
17 |
0.029
|
|
|
|
regulation of fibroblast proliferation
|
GO:0048145 |
34 |
0.029
|
|
|
|
zygote asymmetric cell division
|
GO:0010070 |
2 |
0.029
|
|
|
|
b cell lineage commitment
|
GO:0002326 |
4 |
0.029
|
|
|
|
dna biosynthetic process
|
GO:0071897 |
22 |
0.029
|
|
|
|
negative regulation of organ growth
|
GO:0046621 |
17 |
0.028
|
|
|
|
dna replication checkpoint
|
GO:0000076 |
2 |
0.028
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.028
|
|
|
|
positive regulation of mirna metabolic process
|
GO:2000630 |
1 |
0.028
|
|
|
|
posttranscriptional gene silencing
|
GO:0016441 |
10 |
0.028
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.028
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.027
|
|
|
|
positive regulation of dna templated transcription elongation
|
GO:0032786 |
2 |
0.027
|
|
|
|
regulation of rig i signaling pathway
|
GO:0039535 |
2 |
0.027
|
|
|
|
thymus development
|
GO:0048538 |
41 |
0.027
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.027
|
|
|
|
mitotic recombination
|
GO:0006312 |
3 |
0.027
|
|
|
|
positive regulation of cysteine type endopeptidase activity
|
GO:2001056 |
39 |
0.027
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.027
|
|
|
|
rna 3 end processing
|
GO:0031123 |
20 |
0.027
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.027
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.027
|
|
|
|
negative regulation of phosphatidylinositol 3 kinase activity
|
GO:0043553 |
1 |
0.027
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.027
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.027
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.027
|
|
|
|
muscle cell apoptotic process
|
GO:0010657 |
18 |
0.026
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.026
|
|
|
|
mitotic spindle assembly checkpoint
|
GO:0007094 |
7 |
0.026
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.026
|
|
|
|
cellular response to increased oxygen levels
|
GO:0036295 |
1 |
0.026
|
|
|
|
negative regulation of anoikis
|
GO:2000811 |
2 |
0.026
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.026
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.026
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.026
|
|
|
|
gene silencing by rna
|
GO:0031047 |
19 |
0.025
|
|
|
|
signal transduction in response to dna damage
|
GO:0042770 |
21 |
0.025
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.025
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.025
|
|
|
|
lipoprotein catabolic process
|
GO:0042159 |
7 |
0.025
|
|
|
|
positive regulation of response to dna damage stimulus
|
GO:2001022 |
14 |
0.025
|
|
|
|
photoreceptor cell maintenance
|
GO:0045494 |
19 |
0.025
|
|
|
|
activation of cysteine type endopeptidase activity involved in apoptotic signaling pathway
|
GO:0097296 |
2 |
0.025
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.025
|
|
|
|
cellular response to starvation
|
GO:0009267 |
57 |
0.024
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
53 |
0.024
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.024
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.024
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.024
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.024
|
|
|
|
regulation of peptidyl serine phosphorylation
|
GO:0033135 |
39 |
0.024
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.024
|
|
|
|
regulation of histone acetylation
|
GO:0035065 |
19 |
0.024
|
|
|
|
positive regulation of metaphase anaphase transition of cell cycle
|
GO:1902101 |
2 |
0.023
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.023
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.023
|
|
|
|
protein depolymerization
|
GO:0051261 |
34 |
0.023
|
|
|
|
germ line stem cell division
|
GO:0042078 |
2 |
0.023
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.023
|
|
|
|
mitotic sister chromatid separation
|
GO:0051306 |
9 |
0.023
|
|
|
|
cellular process regulating host cell cycle in response to virus
|
GO:0060154 |
3 |
0.023
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.023
|
|
|
|
nucleic acid transport
|
GO:0050657 |
18 |
0.022
|
|
|
|
cellular response to decreased oxygen levels
|
GO:0036294 |
18 |
0.022
|
|
|
|
negative regulation of protein depolymerization
|
GO:1901880 |
21 |
0.022
|
|
|
|
negative regulation of oxidative stress induced intrinsic apoptotic signaling pathway
|
GO:1902176 |
4 |
0.022
|
|
|
|
dna geometric change
|
GO:0032392 |
7 |
0.022
|
|
|
|
negative regulation of cell growth
|
GO:0030308 |
44 |
0.022
|
|
|
|
modulation by virus of host morphology or physiology
|
GO:0019048 |
3 |
0.022
|
|
|
|
single fertilization
|
GO:0007338 |
82 |
0.022
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.022
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.022
|
|
|
|
glial cell development
|
GO:0021782 |
54 |
0.022
|
|
|
|
negative regulation of cell size
|
GO:0045792 |
3 |
0.022
|
|
|
|
mitotic sister chromatid cohesion
|
GO:0007064 |
1 |
0.022
|
|
|
|
regulation of mitotic sister chromatid segregation
|
GO:0033047 |
12 |
0.022
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.021
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.021
|
|
|
|
b cell apoptotic process
|
GO:0001783 |
19 |
0.021
|
|
|
|
dna ligation
|
GO:0006266 |
3 |
0.021
|
|
|
|
positive regulation of myelination
|
GO:0031643 |
5 |
0.021
|
|
|
|
negative regulation of cellular protein catabolic process
|
GO:1903363 |
22 |
0.021
|
|
|
|
mrna catabolic process
|
GO:0006402 |
22 |
0.021
|
|
|
|
atp catabolic process
|
GO:0006200 |
55 |
0.021
|
|
|
|
regulation of mrna stability
|
GO:0043488 |
23 |
0.021
|
|
|
|
oocyte differentiation
|
GO:0009994 |
35 |
0.021
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.021
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.021
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.020
|
|
|
|
inner ear receptor cell differentiation
|
GO:0060113 |
61 |
0.020
|
|
|
|
cellular hyperosmotic response
|
GO:0071474 |
0 |
0.020
|
|
|
|
postreplication repair
|
GO:0006301 |
5 |
0.020
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.020
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.020
|
|
|
|
intrinsic apoptotic signaling pathway in response to oxidative stress
|
GO:0008631 |
19 |
0.020
|
|
|
|
negative regulation of gene expression epigenetic
|
GO:0045814 |
15 |
0.020
|
|
|
|
rna localization
|
GO:0006403 |
23 |
0.020
|
|
|
|
viral process
|
GO:0016032 |
41 |
0.020
|
|
|
|
negative regulation of lipid kinase activity
|
GO:0090219 |
1 |
0.020
|
|
|
|
positive regulation of mammary gland involution
|
GO:1903521 |
4 |
0.020
|
|
|
|
regulation of cell cycle g2 m phase transition
|
GO:1902749 |
10 |
0.020
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.020
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.020
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.020
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.020
|
|
|
|
positive regulation of apoptotic process involved in morphogenesis
|
GO:1902339 |
4 |
0.019
|
|
|
|
positive regulation of mitotic cell cycle
|
GO:0045931 |
41 |
0.019
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.019
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.019
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.019
|
|
|
|
mitochondrial membrane organization
|
GO:0007006 |
26 |
0.019
|
|
|
|
response to temperature stimulus
|
GO:0009266 |
55 |
0.019
|
|
|
|
hair follicle morphogenesis
|
GO:0031069 |
29 |
0.019
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.019
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
58 |
0.019
|
|
|
|
cellular response to light stimulus
|
GO:0071482 |
19 |
0.019
|
|
|
|
glycerolipid biosynthetic process
|
GO:0045017 |
50 |
0.019
|
|
|
|
negative regulation of schwann cell proliferation
|
GO:0010626 |
1 |
0.019
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.019
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.019
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.019
|
|
|
|
negative regulation of thymocyte apoptotic process
|
GO:0070244 |
8 |
0.019
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.019
|
|
|
|
positive regulation of leukocyte apoptotic process
|
GO:2000108 |
21 |
0.019
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.019
|
|
|
|
dna conformation change
|
GO:0071103 |
37 |
0.019
|
|